RCBTB1
protein-codingRCC1 and BTB domain containing protein 1, the group of BTB domain containing
Gene summary
This gene encodes a protein with an N-terminal RCC1 domain and a C-terminal BTB (broad complex, tramtrack and bric-a-brac) domain. In rat, over-expression of this gene in vascular smooth muscle cells induced cellular hypertrophy. In rat, the C-terminus of RCBTB1 interacts with the angiotensin II receptor-1A. In humans, this gene maps to a region of chromosome 13q that is frequently deleted in B-cell chronic lymphocytic leukemia and other lymphoid malignancies. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~53.6 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0019516
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0014955
Submitter: Laboratory for Molecular Medicine
This gene-disease relationship has undergone rapid assessment. Classifications are based on preliminary review of gene-disease validity during analysis of genomic sequencing results.
Inheritance Pattern: AR
Disease ID:MONDO:0014955
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0014955
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0019516
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0009979
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0014955
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0014955
Submitter: ClinGen
RCBTB1 was first reported in relation to autosomal recessive RCBTB1-related retinopathy in 2016 (Coppietiers et al., PMID: 27486781). 13 affected individuals from 6 families were reported in the initial publication. All had retinal disease, with phenotypes ranging from retinitis pigmentosa to chorioretinal macular atrophy. 7 of the individuals from the initial publication had extra-ocular features, primarily affecting the thyroid, ovary, and/or inner ear. The RCBTB1 gene was therefore associated with the disease entity retinal dystrophy with or without extraocular anomalies (MIM# 617175). In total, 12 variants (missense, nonsense, and frameshift) that have been reported in 11 probands in 4 publications (PMIDs: 27486781, 33104391, 35057699, 33624564) are included in this curation. A total of 16 affected individuals were reported in those 4 publications. All had retinopathy, and 8/16 (50%) were reported to have one or more extra-ocular feature, such as symptoms affecting the thyroid, ovary, ear, kidney, and/or neurologic system. 4 of these individuals with reported extra-ocular manifestations were from consanguineous families (3 from the same extended family). No clear pattern of extra-ocular features is evident at this time. Therefore, the Retina GCEP has curated this gene for RCBTB1-related retinopathy, as opposed to a syndromic entity. The mechanism of pathogenicity is reported to be LOF (PMID: 31494449). While not counted in this curation, members of the Retina GCEP have observed at least 6 additional patients affected with retinopathy with potentially causative RCBTB1 variants and no other molecular genetic diagnosis on panel testing (unpublished, Invitae; unpublished, Blueprint). Of note, there is a report of 3 individuals from 2 families with heterozygous RCBTB1 variants with Coats disease and/or FEVR (Wu et al., 2016; PMID: 26908610). However, others report that RCBTB1 does not appear to be enriched in FEVR cohorts as compared to controls (Yang et al., 2021; PMID: 33104391). At this time, there is not sufficient evidence to curate this gene for these phenotypes or autosomal dominant inheritance. This gene-disease association of RCBTB1 with autosomal recessive retinopathy is also supported by experimental evidence including expression studies and in vitro functional assays (PMIDs: 27486781, 34617687). Expression analysis of mRNA shows strong expression in human retina and limited expression in RPE, and RCBTB1 immunoreactivity in the murine retina mainly localized to the inner retina (PMID: 27486781). In addition, RCBTB1 expression reduced in patient RPE compared to control (PMID: 34617687). In cultured RPE cells, RCBTB1 expression reduced in patient RPE compared to control (PMID: 34617687) and morphologic differences (flattened appearance and reduced surface microvillus densities) were observed in cilia in patient-derived RPE cells as compared to control cells (PMID: 34617687). In summary, RCBTB1 is definitively associated with autosomal recessive RCBTB1-related retinopathy. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time.
Inheritance Pattern: AR
Disease ID:MONDO:0014955
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Ophthalmologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to RCBTB1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_018191.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | 97 | 5 | 105 | ||
| missense | 5 | 199 | 5 | 1 | 210 | |
| nonsense | 5 | 6 | 2 | 13 | ||
| start loss | 0 | |||||
| frameshift | 9 | 3 | 1 | 13 | ||
| splice donor/acceptor (+/-2bp) | 10 | 4 | 1 | 15 | ||
| Total | 14 | 24 | 209 | 103 | 6 | 356 |
Highest pathogenic variant AF is 0.00009356021
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_060661.3 | 11 | MANE Select | |
| Ensembl | ENSP00000367552.2 | 11 | MANE Select | |
| RefSeq | NP_001339429.1 | 11 | Standard | |
| RefSeq | NP_001339430.1 | 11 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| rcbtb1 | Danio rerio | Structure: ocular blood vessel Quality: decreased area abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- chromatin organization
- cell cycle
Cellular Component
- nucleus
- cytoplasm
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000378302
- Coding exons
- 11
- Length
- 53638
- Individuals with no LoFs
- 125703
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 44
- Defined
- 125747
- p
- 0.000175
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.03 | 245 | 295 | 0.831 | 0.0000159 | 3455 |
| Missense (PolyPhen) | 57 | 81.485 | 0.69951 | 1008 | ||
| Synonymous | 0.335 | 115 | 120 | 0.961 | 0.00000743 | 1032 |
| Loss of Function | 2.39 | 14 | 27.6 | 0.508 | 0.00000137 | 322 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0.00029 | 0.00029 | rare |
| Ashkenazi Jewish | 0.00010 | 0.000099 | rare |
| East Asian | 0.00049 | 0.00049 | rare |
| Finnish | 0.00014 | 0.00014 | rare |
| European (Non-Finnish) | 0.00014 | 0.00013 | rare |
| South Asian | 0.00014 | 0.00013 | rare |
| Other | 0.00033 | 0.00033 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: May be involved in cell cycle regulation by chromatin remodeling. {ECO:0000269|PubMed:11306461}.;
Recessive Scores
- pRec
- 0.120
Intolerance Scores
- LoFtool
- 0.462
- RVIS EVS
- -0.58
- RVIS percentile EVS
- 18.78
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.595
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |